Year |
Citation |
Score |
2024 |
Liubomirski Y, Tiram G, Scomparin A, Gnaim S, Das S, Gholap S, Ge L, Yeini E, Shelef O, Zauberman A, Berger N, Kalimi D, Toister-Achituv M, Schröter C, Dickgiesser S, ... ... Satchi-Fainaro R, et al. Potent antitumor activity of anti-HER2 antibody-topoisomerase I inhibitor conjugate based on self-immolative dendritic dimeric-linker. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 38228272 DOI: 10.1016/j.jconrel.2024.01.025 |
0.323 |
|
2023 |
Matos AI, Peres C, Carreira B, Moura LIF, Acúrcio RC, Vogel T, Wegener E, Ribeiro F, Afonso MB, Santos FMF, Martínez-Barriocanal Á, Arango D, Viana AS, Góis PMP, Silva LC, ... ... Satchi-Fainaro R, et al. Polyoxazoline-Based Nanovaccine Synergizes with Tumor-Associated Macrophage Targeting and Anti-PD-1 Immunotherapy against Solid Tumors. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2300299. PMID 37434063 DOI: 10.1002/advs.202300299 |
0.314 |
|
2023 |
Ofek P, Yeini E, Arad G, Danilevsky A, Pozzi S, Luna CB, Dangoor SI, Grossman R, Ram Z, Shomron N, Brem H, Hyde TM, Geiger T, Satchi-Fainaro R. Deoxyhypusine hydroxylase: A novel therapeutic target differentially expressed in short-term vs long-term survivors of glioblastoma. International Journal of Cancer. PMID 37141410 DOI: 10.1002/ijc.34545 |
0.31 |
|
2022 |
Epshtein Y, Blau R, Pisarevsky E, Koshrovski-Michael S, Ben-Shushan D, Pozzi S, Shenbach-Koltin G, Fridrich L, Buzhor M, Krivitsky A, Dey P, Satchi-Fainaro R. Polyglutamate-based nanoconjugates for image-guided surgery and post-operative melanoma metastases prevention. Theranostics. 12: 6339-6362. PMID 36168618 DOI: 10.7150/thno.72941 |
0.774 |
|
2021 |
Krivitsky A, Pozzi S, Yeini E, Israeli Dangoor S, Zur T, Golan S, Krivitsky V, Albeck N, Pisarevsky E, Ofek P, Madi A, Satchi-Fainaro R. Sulfonated Amphiphilic Poly(α)glutamate Amine-A Potential siRNA Nanocarrier for the Treatment of Both Chemo-Sensitive and Chemo-Resistant Glioblastoma Tumors. Pharmaceutics. 13. PMID 34959480 DOI: 10.3390/pharmaceutics13122199 |
0.331 |
|
2021 |
Neufeld L, Yeini E, Reisman N, Shtilerman Y, Ben-Shushan D, Pozzi S, Madi A, Tiram G, Eldar-Boock A, Ferber S, Grossman R, Ram Z, Satchi-Fainaro R. Microengineered perfusable 3D-bioprinted glioblastoma model for in vivo mimicry of tumor microenvironment. Science Advances. 7. PMID 34407932 DOI: 10.1126/sciadv.abi9119 |
0.302 |
|
2020 |
Pisarevsky E, Blau R, Epshtein Y, Ben-Shushan D, Eldar-Boock A, Tiram G, Koshrovski-Michael S, Scomparin A, Pozzi S, Krivitsky A, Shenbach-Koltin G, Yeini E, Fridrich L, White R, Satchi-Fainaro R. Rational Design of Polyglutamic Acid Delivering an Optimized Combination of Drugs Targeting Mutated BRAF and MEK in Melanoma. Advanced Therapeutics. 3. PMID 35754977 DOI: 10.1002/adtp.202000028 |
0.695 |
|
2019 |
Zinger A, Koren L, Adir O, Poley M, Alyan M, Yaari Z, Noor N, Krinsky N, Simon A, Gibori H, Krayem M, Mumblat Y, Kasten S, Ofir S, Fridman E, ... ... Satchi-Fainaro R, et al. Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors. Acs Nano. PMID 31503443 DOI: 10.1021/Acsnano.9B02395 |
0.44 |
|
2019 |
Doron H, Amer M, Ershaid N, Blazquez R, Shani O, Lahav TG, Cohen N, Adler O, Hakim Z, Pozzi S, Scomparin A, Cohen J, Yassin M, Monteran L, Grossman R, ... ... Satchi-Fainaro R, et al. Inflammatory Activation of Astrocytes Facilitates Melanoma Brain Tropism via the CXCL10-CXCR3 Signaling Axis. Cell Reports. 28: 1785-1798.e6. PMID 31412247 DOI: 10.1016/J.Celrep.2019.07.033 |
0.339 |
|
2019 |
Malfanti A, Scomparin A, Pozzi S, Gibori H, Krivitsky A, Blau R, Satchi-Fainaro R, Mastrotto F, Caliceti P, Salmaso S. Oligo-guanidyl targeted bioconjugates forming rod shaped polyplexes as a new nanoplatform for oligonucleotide delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. 310: 58-73. PMID 31400381 DOI: 10.1016/J.Jconrel.2019.08.005 |
0.315 |
|
2019 |
Conniot J, Scomparin A, Peres C, Yeini E, Pozzi S, Matos AI, Kleiner R, Moura LIF, Zupančič E, Viana AS, Doron H, Gois PMP, Erez N, Jung S, Satchi-Fainaro R, et al. Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators. Nature Nanotechnology. PMID 31384037 DOI: 10.1038/S41565-019-0512-0 |
0.327 |
|
2018 |
Krivitsky A, Krivitsky V, Polyak D, Scomparin A, Eliyahu S, Gibori H, Yeini E, Pisarevsky E, Blau R, Satchi-Fainaro R. Molecular Weight-Dependent Activity of Aminated Poly(α)glutamates as siRNA Nanocarriers. Polymers. 10. PMID 30966582 DOI: 10.3390/Polym10050548 |
0.741 |
|
2018 |
Blau R, Epshtein Y, Pisarevsky E, Tiram G, Israeli Dangoor S, Yeini E, Krivitsky A, Eldar-Boock A, Ben-Shushan D, Gibori H, Scomparin A, Green O, Ben-Nun Y, Merquiol E, Doron H, ... ... Satchi-Fainaro R, et al. Image-guided surgery using near-infrared Turn-ON fluorescent nanoprobes for precise detection of tumor margins. Theranostics. 8: 3437-3460. PMID 30026858 DOI: 10.7150/thno.23853 |
0.759 |
|
2018 |
Sainz V, Moura LIF, Peres C, Matos AI, Viana AS, Wagner AM, Vela Ramirez JE, Barata T, Gaspar M, Brocchini S, Zloh M, Peppas NA, Satchi-Fainaro R, Florindo HF. α-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effectin melanoma. Acta Biomaterialia. PMID 29940370 DOI: 10.1016/J.Actbio.2018.06.029 |
0.393 |
|
2018 |
Tiram G, Ferber S, Ofek P, Eldar-Boock A, Ben-Shushan D, Yeini E, Krivitsky A, Blatt R, Almog N, Henkin J, Amsalem O, Yavin E, Cohen G, Lazarovici P, Lee JS, ... ... Satchi-Fainaro R, et al. Reverting the molecular fingerprint of tumor dormancy as a therapeutic strategy for glioblastoma. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201701568R. PMID 29856660 DOI: 10.1096/Fj.201701568R |
0.417 |
|
2018 |
Shabat D, Gnaim S, Scomparin A, Das S, Satchi-Fainaro R. Real-Time Monitoring of Prodrug Activation by Direct-Mode of Chemiluminescence. Angewandte Chemie (International Ed. in English). PMID 29786931 DOI: 10.1002/Anie.201804816 |
0.328 |
|
2018 |
Vossen LI, Markovsky E, Eldar-Boock A, Tschiche HR, Wedepohl S, Pisarevsky E, Satchi-Fainaro R, Calderón M. PEGylated dendritic polyglycerol conjugate targeting NCAM-expressing neuroblastoma: Limitations and challenges. Nanomedicine : Nanotechnology, Biology, and Medicine. 14: 1169-1179. PMID 29471169 DOI: 10.1016/J.Nano.2018.02.009 |
0.78 |
|
2018 |
Eilon-Shaffer T, Roth-Konforti M, Eldar-Boock A, Satchi-Fainaro R, Shabat D. ortho-Chlorination of phenoxy 1,2-dioxetane yields superior chemiluminescent probes for in vitro and in vivo imaging. Organic & Biomolecular Chemistry. PMID 29451576 DOI: 10.1039/C8Ob00087E |
0.346 |
|
2018 |
Zupančič E, Curato C, Kim JS, Yeini E, Porat Z, Viana AS, Globerson-Levin A, Waks T, Eshhar Z, Moreira JN, Satchi-Fainaro R, Eisenbach L, Jung S, Florindo HF. Nanoparticulate vaccine inhibits tumor growth via improved T cell recruitment into melanoma and huHER2 breast cancer. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 29306001 DOI: 10.1016/J.Nano.2017.12.011 |
0.374 |
|
2018 |
Gibori H, Eliyahu S, Krivitsky A, Ben-Shushan D, Epshtein Y, Tiram G, Blau R, Ofek P, Lee JS, Ruppin E, Landsman L, Barshack I, Golan T, Merquiol E, Blum G, ... Satchi-Fainaro R, et al. Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer. Nature Communications. 9: 16. PMID 29295989 DOI: 10.1038/S41467-017-02283-9 |
0.38 |
|
2017 |
Krivitsky A, Polyak D, Scomparin A, Eliyahu S, Ofek P, Tiram G, Kalinski H, Avkin-Nachum S, Gracia NF, Albertazzi L, Satchi-Fainaro R. Amphiphilic poly(α)glutamate polymeric micelles for systemic administration of siRNA to tumors. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 29127036 DOI: 10.1016/J.Nano.2017.10.012 |
0.444 |
|
2017 |
Ferber S, Tiram G, Sousa-Herves A, Eldar-Boock A, Krivitsky A, Scomparin A, Yeini E, Ofek P, Ben-Shushan D, Vossen LI, Licha K, Grossman R, Ram Z, Henkin J, Ruppin E, ... ... Satchi-Fainaro R, et al. Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome. Elife. 6. PMID 28976305 DOI: 10.7554/Elife.25281 |
0.452 |
|
2017 |
Scomparin A, Florindo HF, Tiram G, Ferguson EL, Satchi-Fainaro R. Two-step polymer- and liposome- enzyme prodrug therapies for cancer: PDEPT and PELT concepts and future perspectives. Advanced Drug Delivery Reviews. PMID 28916497 DOI: 10.1016/J.Addr.2017.09.011 |
0.386 |
|
2017 |
Satchi-Fainaro R, Vicent MJ, Richardson S. Professor Ruth Duncan: A Pioneer in the Field of Polymer Therapeutics. Journal of Drug Targeting. 1-3. PMID 28832230 DOI: 10.1080/1061186X.2017.1371722 |
0.347 |
|
2017 |
Eldar-Boock A, Blau R, Ryppa C, Baabur-Cohen H, Many A, Vicent MJ, Kratz F, Sanchis J, Satchi-Fainaro R. Integrin-Targeted Nano-Sized Polymeric Systems for Paclitaxel Conjugation: A Comparative Study. Journal of Drug Targeting. 1-41. PMID 28737432 DOI: 10.1080/1061186X.2017.1358727 |
0.468 |
|
2017 |
Markovsky E, Vax E, Ben-Shushan D, Eldar-Boock A, Shukrun R, Yeini E, Barshack I, Caspi R, Harari-Steinberg O, Pode-Shakked N, Dekel B, Satchi-Fainaro R. Wilms Tumor NCAM-Expressing Cancer Stem Cells as Potential Therapeutic Target for Polymeric Nanomedicine. Molecular Cancer Therapeutics. 16: 2462-2472. PMID 28729402 DOI: 10.1158/1535-7163.Mct-17-0184 |
0.5 |
|
2017 |
Ferguson EL, Scomparin A, Hailu H, Satchi-Fainaro R. HPMA Copolymer-phospholipase C and Dextrin-Phospholipase A2 as Model Triggers for Polymer Enzyme Liposome Therapy (PELT). Journal of Drug Targeting. 1-33. PMID 28728446 DOI: 10.1080/1061186X.2017.1358726 |
0.357 |
|
2017 |
Ofek P, Tiram G, Satchi-Fainaro R. Angiogenesis regulation by nanocarriers bearing RNA interference. Advanced Drug Delivery Reviews. 119: 3-19. PMID 28163106 DOI: 10.1016/J.Addr.2017.01.008 |
0.355 |
|
2017 |
Markovsky E, Eldar-Boock A, Ben-Shushan D, Baabur-Cohen H, Yeini E, Pisarevsky E, Many A, Aviel-Ronen S, Barshack I, Satchi-Fainaro R. Targeting NCAM-expressing neuroblastoma with polymeric precision nanomedicine. Journal of Controlled Release : Official Journal of the Controlled Release Society. 249: 162-172. PMID 28159518 DOI: 10.1016/J.Jconrel.2017.01.044 |
0.784 |
|
2017 |
Ferber S, Tiram G, Sousa-Herves A, Eldar-Boock A, Krivitsky A, Scomparin A, Yeini E, Ofek P, Ben-Shushan D, Vossen LI, Licha K, Grossman R, Ram Z, Henkin J, Ruppin E, ... ... Satchi-Fainaro R, et al. Author response: Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome Elife. DOI: 10.7554/Elife.25281.027 |
0.416 |
|
2016 |
Alishekevitz D, Gingis-Velitski S, Kaidar-Person O, Gutter-Kapon L, Scherer SD, Raviv Z, Merquiol E, Ben-Nun Y, Miller V, Rachman-Tzemah C, Timaner M, Mumblat Y, Ilan N, Loven D, Hershkovitz D, ... Satchi-Fainaro R, et al. Macrophage-Induced Lymphangiogenesis and Metastasis following Paclitaxel Chemotherapy Is Regulated by VEGFR3. Cell Reports. 17: 1344-1356. PMID 27783948 DOI: 10.1016/J.Celrep.2016.09.083 |
0.407 |
|
2016 |
Shatsberg Z, Zhang X, Ofek P, Malhotra S, Krivitsky A, Scomparin A, Tiram G, Calderón M, Haag R, Satchi-Fainaro R. Functionalized nanogels carrying an anticancer microRNA for glioblastoma therapy. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 27569663 DOI: 10.1016/J.Jconrel.2016.08.029 |
0.351 |
|
2016 |
Gnaim S, Scomparin A, Li X, Baran PS, Rader C, Satchi-Fainaro R, Shabat D. Tagging the Untaggable: A Difluoroalkyl-Sulfinate Ketone-Based Reagent for Direct C-H Functionalization of Bioactive Heteroarenes. Bioconjugate Chemistry. PMID 27494153 DOI: 10.1021/Acs.Bioconjchem.6B00382 |
0.327 |
|
2016 |
Blau R, Krivitsky A, Epshtein Y, Satchi-Fainaro R. Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine? Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 27: 39-58. PMID 27449597 DOI: 10.1016/J.Drup.2016.06.003 |
0.355 |
|
2016 |
Krivitsky A, Polyak D, Scomparin A, Eliyahu S, Ori A, Avkin Nachum S, Krivitsky V, Satchi-Fainaro R. Structure-function correlation of aminated poly(α)glutamate as siRNA nanocarriers. Biomacromolecules. PMID 27377188 DOI: 10.1021/Acs.Biomac.6B00555 |
0.376 |
|
2016 |
Baabur-Cohen H, Vossen L, Krüger HR, Eldar-Boock A, Yeini E, Landa-Rouben N, Tiram G, Wedepohl S, Markovsky E, Leor J, Calderón M, Satchi-Fainaro R. In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 27374630 DOI: 10.1016/J.Jconrel.2016.06.037 |
0.469 |
|
2016 |
Polyak D, Krivitsky A, Scomparin A, Eliyahu S, Kalinski H, Avkin-Nachum S, Satchi-Fainaro R. Systemic delivery of siRNA by aminated poly(α)glutamate for the treatment of solid tumors. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 27356019 DOI: 10.1016/J.Jconrel.2016.06.034 |
0.499 |
|
2016 |
Ofek P, Calderón M, Mehrabadi FS, Krivitsky A, Ferber S, Tiram G, Yerushalmi N, Kredo-Russo S, Grossman R, Ram Z, Haag R, Satchi-Fainaro R. Restoring the Oncosuppressor Activity of MicroRNA-34a in Glioblastoma Using a Polyglycerol-based Polyplex. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 27262933 DOI: 10.1016/J.Nano.2016.05.016 |
0.346 |
|
2016 |
Schwartz H, Blacher E, Amer M, Livneh N, Abramovitz L, Klein A, Ben-Shushan D, Soffer S, Blazquez R, Barrantes-Freer A, Müller M, Müller-Decker K, Stein R, Tsarfaty G, Satchi-Fainaro R, et al. Incipient melanoma brain metastases instigate astrogliosis and neuroinflammation. Cancer Research. PMID 27261506 DOI: 10.1158/0008-5472.Can-16-0485 |
0.307 |
|
2016 |
Golan M, Feinshtein V, Polyak D, Scomparin A, Satchi-Fainaro R, David A. Inhibition of Gene Expression and Cancer Cell Migration by CD44v3/6-Targeted Polyion Complexes. Bioconjugate Chemistry. 27: 947-60. PMID 26974863 DOI: 10.1021/Acs.Bioconjchem.6B00020 |
0.478 |
|
2016 |
Tiram G, Segal E, Krivitsky A, Shreberk-Hassidim R, Ofek P, Ferber S, Udagawa T, Edry L, Shomron N, Roniger M, Kerem B, Shaked Y, Aviel-Ronen S, Barshack I, Calderon M, ... ... Satchi-Fainaro R, et al. Identification of Dormancy-Associated MicroRNAs for the Design of Osteosarcoma-Targeted Dendritic Polyglycerol Nanopolyplexes. Acs Nano. PMID 26815014 DOI: 10.1021/Acsnano.5B06189 |
0.415 |
|
2016 |
Ofek P, Dromi N, Yerushalmi N, Kredo-Russo S, Grossman R, Ram Z, Satchi-Fainaro R. Abstract B05: Patient-derived GBM tumors versus patient-derived primary cells and GBM cell lines: lessons from microRNA profiling Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Pdx16-B05 |
0.379 |
|
2016 |
Schwartz H, Blacher E, Amer M, Livneh N, Klein A, Ben-Shushan D, Soffer S, Stein R, Satchi-Fainaro R, Umansky V, Pukrop T, Erez N. Abstract C26: Melanoma brain metastasis is facilitated by instigation of reactive astrogliosis Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-C26 |
0.343 |
|
2016 |
Tiram G, Ofek P, Udagawa T, Shomron N, Roniger M, Kerem B, Shaked Y, Aviel-Ronen S, Barshack I, Calderon M, Haag R, Satchi-Fainaro R. Abstract B42: Dysregulation of key microRNAs controlling tumor-host interactions triggers escape from osteosarcoma dormancy Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-B42 |
0.377 |
|
2016 |
Tiram G, Ferber S, Satchi-Fainaro R. Abstract B39: Identifying molecular signatures of tumor dormancy as a basis for the rational design of precision nanomedicines Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-B39 |
0.474 |
|
2015 |
Scomparin A, Polyak D, Krivitsky A, Satchi-Fainaro R. Achieving successful delivery of oligonucleotides--From physico-chemical characterization to in vivo evaluation. Biotechnology Advances. 33: 1294-309. PMID 25916823 DOI: 10.1016/J.Biotechadv.2015.04.008 |
0.388 |
|
2015 |
Scomparin A, Salmaso S, Eldar-Boock A, Ben-Shushan D, Ferber S, Tiram G, Shmeeda H, Landa-Rouben N, Leor J, Caliceti P, Gabizon A, Satchi-Fainaro R. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index. Journal of Controlled Release : Official Journal of the Controlled Release Society. 208: 106-20. PMID 25869964 DOI: 10.1016/J.Jconrel.2015.04.009 |
0.453 |
|
2015 |
Bonzi G, Salmaso S, Scomparin A, Eldar-Boock A, Satchi-Fainaro R, Caliceti P. Novel pullulan bioconjugate for selective breast cancer bone metastases treatment. Bioconjugate Chemistry. 26: 489-501. PMID 25613006 DOI: 10.1021/Bc500614B |
0.31 |
|
2014 |
Ben-Shushan D, Markovsky E, Gibori H, Tiram G, Scomparin A, Satchi-Fainaro R. Overcoming obstacles in microRNA delivery towards improved cancer therapy. Drug Delivery and Translational Research. 4: 38-49. PMID 25786616 DOI: 10.1007/S13346-013-0160-0 |
0.302 |
|
2014 |
Ferber S, Tiram G, Satchi-Fainaro R. Monitoring functionality and morphology of vasculature recruited by factors secreted by fast-growing tumor-generating cells. Journal of Visualized Experiments : Jove. e51525. PMID 25490071 DOI: 10.3791/51525 |
0.366 |
|
2014 |
Markovsky E, Baabur-Cohen H, Satchi-Fainaro R. Anticancer polymeric nanomedicine bearing synergistic drug combination is superior to a mixture of individually-conjugated drugs. Journal of Controlled Release : Official Journal of the Controlled Release Society. 187: 145-57. PMID 24862318 DOI: 10.1016/J.Jconrel.2014.05.025 |
0.438 |
|
2014 |
Kisin-Finfer E, Ferber S, Blau R, Satchi-Fainaro R, Shabat D. Synthesis and evaluation of new NIR-fluorescent probes for cathepsin B: ICT versus FRET as a turn-ON mode-of-action. Bioorganic & Medicinal Chemistry Letters. 24: 2453-8. PMID 24767838 DOI: 10.1016/J.Bmcl.2014.04.022 |
0.331 |
|
2014 |
Tiram G, Scomparin A, Ofek P, Satchi-Fainaro R. Interfering cancer with polymeric siRNA nanomedicines. Journal of Biomedical Nanotechnology. 10: 50-66. PMID 24724498 DOI: 10.1166/Jbn.2014.1715 |
0.413 |
|
2014 |
Ferber S, Baabur-Cohen H, Blau R, Epshtein Y, Kisin-Finfer E, Redy O, Shabat D, Satchi-Fainaro R. Polymeric nanotheranostics for real-time non-invasive optical imaging of breast cancer progression and drug release. Cancer Letters. 352: 81-9. PMID 24614283 DOI: 10.1016/J.Canlet.2014.02.022 |
0.401 |
|
2014 |
Eldar-Boock A, Ben-Shushan D, Sanchis J, Lupu R, Vicent MJ, Satchi-Fainaro R. Abstract LB-196: Preventing breast cancer metastases with an anti-angiogenic and anticancer RGD-bearing nanomedicine Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-196 |
0.462 |
|
2014 |
Ferber S, Tiram G, Amsalem O, Yavin E, Almog N, Henkin J, Calderon M, Haag R, Satchi-Fainaro R. Abstract LB-104: Reverting the angiogenic switch of glioblastoma with a nanopolyplex based on the molecular fingerprint of tumor dormancy Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-104 |
0.448 |
|
2014 |
Ofek P, Calderon M, Sheikhi-Mehrabadi F, Ferber S, Haag R, Satchi-Fainaro R. Abstract 4391: Multi-modal nanomedicine for glioblastoma Cancer Research. 74: 4391-4391. DOI: 10.1158/1538-7445.Am2014-4391 |
0.38 |
|
2014 |
Tiram G, Ferber S, Ofek P, Shomron N, Udagawa T, Aviel-Ronen S, Barshack I, Satchi-Fainaro R. Abstract 4219: miR-34a, miR-93 and miR-200c - novel molecular regulators of osteosarcoma dormancy Cancer Research. 74: 4219-4219. DOI: 10.1158/1538-7445.Am2014-4219 |
0.333 |
|
2013 |
Eldar-Boock A, Polyak D, Scomparin A, Satchi-Fainaro R. Nano-sized polymers and liposomes designed to deliver combination therapy for cancer. Current Opinion in Biotechnology. 24: 682-9. PMID 23726153 DOI: 10.1016/J.Copbio.2013.04.014 |
0.43 |
|
2013 |
Miller K, Clementi C, Polyak D, Eldar-Boock A, Benayoun L, Barshack I, Shaked Y, Pasut G, Satchi-Fainaro R. Poly(ethylene glycol)-paclitaxel-alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases. Biomaterials. 34: 3795-806. PMID 23434349 DOI: 10.1016/J.Biomaterials.2013.01.052 |
0.407 |
|
2013 |
Benayoun L, Schaffer M, Bril R, Gingis-Velitski S, Segal E, Nevelsky A, Satchi-Fainaro R, Shaked Y. Porfimer-sodium (Photofrin-II) in combination with ionizing radiation inhibits tumor-initiating cell proliferation and improves glioblastoma treatment efficacy Cancer Biology and Therapy. 14: 64-74. PMID 23114641 DOI: 10.4161/Cbt.22630 |
0.429 |
|
2013 |
Herzog IM, Feldman M, Eldar-Boock A, Satchi-Fainaro R, Fridman M. Design of membrane targeting tobramycin-based cationic amphiphiles with reduced hemolytic activity Medchemcomm. 4: 120-124. DOI: 10.1039/C2Md20162C |
0.347 |
|
2013 |
Polyak D, Eldar-Boock A, Baabur-Cohen H, Satchi-Fainaro R. Polymer conjugates for focal and targeted delivery of drugs Polymers For Advanced Technologies. 24: 777-790. DOI: 10.1002/Pat.3158 |
0.469 |
|
2012 |
Satchi-Fainaro R, Ferber S, Segal E, Ma L, Dixit N, Ijaz A, Hlatky L, Abdollahi A, Almog N. Prospective identification of glioblastoma cells generating dormant tumors. Plos One. 7: e44395. PMID 22970208 DOI: 10.1371/Journal.Pone.0044395 |
0.432 |
|
2012 |
Benayoun L, Gingis-Velitski S, Voloshin T, Segal E, Segev R, Munster M, Bril R, Satchi-Fainaro R, Scherer SJ, Shaked Y. Tumor-initiating cells of various tumor types exhibit differential angiogenic properties and react differently to antiangiogenic drugs. Stem Cells (Dayton, Ohio). 30: 1831-41. PMID 22782858 DOI: 10.1002/Stem.1170 |
0.449 |
|
2012 |
Markovsky E, Baabur-Cohen H, Eldar-Boock A, Omer L, Tiram G, Ferber S, Ofek P, Polyak D, Scomparin A, Satchi-Fainaro R. Administration, distribution, metabolism and elimination of polymer therapeutics. Journal of Controlled Release : Official Journal of the Controlled Release Society. 161: 446-60. PMID 22286005 DOI: 10.1016/J.Jconrel.2011.12.021 |
0.364 |
|
2012 |
Ofek P, Fischer W, Calderon M, Haag R, Satchi-Fainaro R. Abstract 5650: Targeting siRNA to tumors and their stroma as a dual anticancer and anti-angiogenic therapy Cancer Research. 72: 5650-5650. DOI: 10.1158/1538-7445.Am2012-5650 |
0.441 |
|
2012 |
Ferber S, Segal E, Almog N, Satchi-Fainaro R. Abstract 5238: Impaired angiogenesis as a hallmark of prolonged tumor dormancy in a mouse model of human glioblastoma Cancer Research. 72: 5238-5238. DOI: 10.1158/1538-7445.Am2012-5238 |
0.376 |
|
2012 |
Tiram G, Segal E, Sherberk R, Bachar G, Ofek P, Udagawa T, Edry L, Shomron N, Satchi-Fainaro R. Abstract 5235: Uncovering tumor-host molecular and cellular interactions involved in tumor dormancy using microRNAs Cancer Research. 72: 5235-5235. DOI: 10.1158/1538-7445.Am2012-5235 |
0.398 |
|
2012 |
Eldar-Boock A, Sanchis J, Lupu R, Vicent MJ, Satchi-Fainaro R. Abstract 5225: Correlation between αvβ3 integrin expression, paclitaxel resistance and RGD-bearing conjugate efficacy Cancer Research. 72: 5225-5225. DOI: 10.1158/1538-7445.Am2012-5225 |
0.505 |
|
2012 |
Tiram G, Segal E, Bachar G, Shreberk R, Ofek P, Satchi-Fainaro R. Abstract 4643: Shedding light on the molecular basis of tumor dormancy using antiangiogenic nanomedicines Cancer Research. 72: 4643-4643. DOI: 10.1158/1538-7445.Am2012-4643 |
0.362 |
|
2011 |
Karton-Lifshin N, Segal E, Omer L, Portnoy M, Satchi-Fainaro R, Shabat D. A unique paradigm for a Turn-ON near-infrared cyanine-based probe: noninvasive intravital optical imaging of hydrogen peroxide. Journal of the American Chemical Society. 133: 10960-5. PMID 21631116 DOI: 10.1021/Ja203145V |
0.301 |
|
2011 |
Clementi C, Miller K, Mero A, Satchi-Fainaro R, Pasut G. Dendritic poly(ethylene glycol) bearing paclitaxel and alendronate for targeting bone neoplasms. Molecular Pharmaceutics. 8: 1063-72. PMID 21608527 DOI: 10.1021/Mp2001445 |
0.424 |
|
2011 |
Miller K, Eldar-Boock A, Polyak D, Segal E, Benayoun L, Shaked Y, Satchi-Fainaro R. Antiangiogenic antitumor activity of HPMA copolymer-paclitaxel-alendronate conjugate on breast cancer bone metastasis mouse model. Molecular Pharmaceutics. 8: 1052-62. PMID 21545170 DOI: 10.1021/Mp200083N |
0.483 |
|
2011 |
Segal E, Pan H, Benayoun L, Kopečková P, Shaked Y, Kopeček J, Satchi-Fainaro R. Enhanced anti-tumor activity and safety profile of targeted nano-scaled HPMA copolymer-alendronate-TNP-470 conjugate in the treatment of bone malignances. Biomaterials. 32: 4450-63. PMID 21429572 DOI: 10.1016/J.Biomaterials.2011.02.059 |
0.436 |
|
2011 |
Eldar-Boock A, Miller K, Sanchis J, Lupu R, Vicent MJ, Satchi-Fainaro R. Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel Biomaterials. 32: 3862-3874. PMID 21376390 DOI: 10.1016/J.Biomaterials.2011.01.073 |
0.51 |
|
2011 |
Scomparin A, Salmaso S, Bersani S, Satchi-Fainaro R, Caliceti P. Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 42: 547-58. PMID 21371555 DOI: 10.1016/J.Ejps.2011.02.012 |
0.383 |
|
2011 |
Polyak D, Ryppa C, Eldar-Boock A, Ofek P, Many A, Licha K, Kratz F, Satchi-Fainaro R. Development of PEGylated doxorubicin-E-[c(RGDfK)2] conjugate for integrin-targeted cancer therapy Polymers For Advanced Technologies. 22: 103-113. DOI: 10.1002/Pat.1731 |
0.456 |
|
2010 |
Marom H, Miller K, Bechor-Bar Y, Tsarfaty G, Satchi-Fainaro R, Gozin M. Toward development of targeted nonsteroidal antiandrogen-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-gadolinium complex for prostate cancer diagnostics. Journal of Medicinal Chemistry. 53: 6316-25. PMID 20715870 DOI: 10.1021/Jm100289B |
0.316 |
|
2010 |
Ofek P, Fischer W, Calderón M, Haag R, Satchi-Fainaro R. In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers The Faseb Journal. 24: 3122-3134. PMID 20385622 DOI: 10.1096/Fj.09-149641 |
0.448 |
|
2009 |
Segal E, Satchi-Fainaro R. Design and development of polymer conjugates as anti-angiogenic agents. Advanced Drug Delivery Reviews. 61: 1159-76. PMID 19699248 DOI: 10.1016/J.Addr.2009.06.005 |
0.483 |
|
2009 |
Erez R, Segal E, Miller K, Satchi-Fainaro R, Shabat D. Enhanced cytotoxicity of a polymer-drug conjugate with triple payload of paclitaxel. Bioorganic & Medicinal Chemistry. 17: 4327-35. PMID 19482477 DOI: 10.1016/J.Bmc.2009.05.028 |
0.41 |
|
2009 |
Segal E, Pan H, Ofek P, Udagawa T, Kopecková P, Kopecek J, Satchi-Fainaro R. Targeting angiogenesis-dependent calcified neoplasms using combined polymer therapeutics. Plos One. 4: e5233. PMID 19381291 DOI: 10.1371/Journal.Pone.0005233 |
0.463 |
|
2009 |
Miller K, Erez R, Segal E, Shabat D, Satchi-Fainaro R. Targeting bone metastases with a bispecific anticancer and antiangiogenic polymer-alendronate-taxane conjugate. Angewandte Chemie (International Ed. in English). 48: 2949-54. PMID 19294707 DOI: 10.1002/Anie.200805133 |
0.38 |
|
2009 |
Stern L, Perry R, Ofek P, Many A, Shabat D, Satchi-Fainaro R. A novel antitumor prodrug platform designed to be cleaved by the endoprotease legumain. Bioconjugate Chemistry. 20: 500-10. PMID 19196156 DOI: 10.1021/Bc800448U |
0.434 |
|
2009 |
Ryppa C, Mann-Steinberg H, Biniossek ML, Satchi-Fainaro R, Kratz F. In vitro and in vivo evaluation of a paclitaxel conjugate with the divalent peptide E-[c(RGDfK)2] that targets integrin alpha v beta 3. International Journal of Pharmaceutics. 368: 89-97. PMID 18992308 DOI: 10.1016/J.Ijpharm.2008.09.055 |
0.345 |
|
2007 |
Chesler L, Goldenberg DD, Seales IT, Satchi-Fainaro R, Grimmer M, Collins R, Struett C, Nguyen KN, Kim G, Tihan T, Bao Y, Brekken RA, Bergers G, Folkman J, Weiss WA. Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma. Cancer Research. 67: 9435-42. PMID 17909053 DOI: 10.1158/0008-5472.Can-07-1316 |
0.439 |
|
2007 |
Nahari D, Satchi-Fainaro R, Chen M, Mitchell I, Task LB, Liu Z, Kihneman J, Carroll AB, Terada LS, Nwariaku FE. Tumor cytotoxicity and endothelial Rac inhibition induced by TNP-470 in anaplastic thyroid cancer. Molecular Cancer Therapeutics. 6: 1329-37. PMID 17431111 DOI: 10.1158/1535-7163.Mct-06-0554 |
0.383 |
|
2007 |
Sagi A, Segal E, Satchi-Fainaro R, Shabat D. Remarkable drug-release enhancement with an elimination-based AB3 self-immolative dendritic amplifier. Bioorganic & Medicinal Chemistry. 15: 3720-7. PMID 17416532 DOI: 10.1016/J.Bmc.2007.03.054 |
0.355 |
|
2006 |
Duncan R, Ringsdorf H, Satchi-Fainaro R. Polymer therapeutics--polymers as drugs, drug and protein conjugates and gene delivery systems: past, present and future opportunities. Journal of Drug Targeting. 14: 337-41. PMID 17092834 DOI: 10.1080/10611860600833856 |
0.316 |
|
2006 |
Becker CM, Wright RD, Satchi-Fainaro R, Funakoshi T, Folkman J, Kung AL, D'Amato RJ. A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy. The American Journal of Pathology. 168: 2074-84. PMID 16723720 DOI: 10.2353/Ajpath.2006.051133 |
0.303 |
|
2005 |
Sjin RMTT, Satchi-Fainaro R, Birsner AE, Ramanujam VMS, Folkman J, Javaherian K. A 27-amino-acid synthetic peptide corresponding to the NH 2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity Cancer Research. 65: 3656-3663. PMID 15867360 DOI: 10.1158/0008-5472.Can-04-1833 |
0.317 |
|
2005 |
Satchi-Fainaro R, Mamluk R, Wang L, Short SM, Nagy JA, Feng D, Dvorak AM, Dvorak HF, Puder M, Mukhopadhyay D, Folkman J. Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin. Cancer Cell. 7: 251-61. PMID 15766663 DOI: 10.1016/J.Ccr.2005.02.007 |
0.385 |
|
2004 |
Satchi-Fainaro R, Puder M, Davies JW, Tran HT, Sampson DA, Greene AK, Corfas G, Folkman J. Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470. Nature Medicine. 10: 255-61. PMID 14981512 DOI: 10.1038/Nm1002 |
0.516 |
|
2003 |
Satchi-Fainaro R, Hailu H, Davies JW, Summerford C, Duncan R. PDEPT: Polymer-directed enzyme prodrug therapy. 2. HPMA copolymer-β-lactamase and HPMA copolymer-C-Dox as a model combination Bioconjugate Chemistry. 14: 797-804. PMID 12862433 DOI: 10.1021/Bc020091K |
0.354 |
|
2002 |
Satchi-Fainaro R. Targeting tumor vasculature: reality or a dream? Journal of Drug Targeting. 10: 529-533. PMID 12683719 DOI: 10.1080/1061186021000051062 |
0.506 |
|
2002 |
Satchi-Fainaro R, Wrasidlo W, Lode HN, Shabat D. Synthesis and characterization of a catalytic antibody-HPMA copolymer-Conjugate as a tool for tumor selective prodrug activation. Bioorganic & Medicinal Chemistry. 10: 3023-9. PMID 12110325 DOI: 10.1016/S0968-0896(02)00156-6 |
0.359 |
|
Low-probability matches (unlikely to be authored by this person) |
2022 |
Pozzi S, Scomparin A, Ben-Shushan D, Yeini E, Ofek P, Nahmad AD, Soffer S, Ionescu A, Ruggiero A, Barzel A, Brem H, Hyde TM, Barshack I, Sinha S, Ruppin E, ... ... Satchi-Fainaro R, et al. MCP-1/CCR2 axis inhibition sensitizes the brain microenvironment against melanoma brain metastasis progression. Jci Insight. PMID 35980743 DOI: 10.1172/jci.insight.154804 |
0.299 |
|
2019 |
Malfanti A, Mastrotto F, Han Y, Král P, Balasso A, Scomparin A, Pozzi S, Satchi-Fainaro R, Salmaso S, Caliceti P. A novel oligo-guanidyl-PEG carrier forming rod-shaped polyplexes. Molecular Pharmaceutics. PMID 30860853 DOI: 10.1021/Acs.Molpharmaceut.9B00014 |
0.299 |
|
2004 |
Périno S, Contino-Pépin C, Satchi-Fainaro R, Butterfield C, Pucci B. Inhibition of angiogenesis by THAM-derived cotelomers endowed with thalidomide moieties. Bioorganic & Medicinal Chemistry Letters. 14: 421-5. PMID 14698173 DOI: 10.1016/J.Bmcl.2003.10.045 |
0.297 |
|
2016 |
Hananya N, Eldar Boock A, Bauer CR, Satchi-Fainaro R, Shabat D. Remarkable Enhancement of Chemiluminescent Signal by Dioxetane-Fluorophore Conjugates: Turn-ON Chemiluminescence Probes with Color Modulation for Sensing and Imaging. Journal of the American Chemical Society. PMID 27652602 DOI: 10.1021/Jacs.6B09173 |
0.295 |
|
2013 |
Chuderland D, Ben-Ami I, Kaplan-Kraicer R, Grossman H, Komsky A, Satchi-Fainaro R, Eldar-Boock A, Ron-El R, Shalgi R. Hormonal regulation of pigment epithelium-derived factor (PEDF) in granulosa cells. Molecular Human Reproduction. 19: 72-81. PMID 23075882 DOI: 10.1093/Molehr/Gas046 |
0.295 |
|
2017 |
Silva AL, Peres C, Conniot J, Matos AI, Moura L, Carreira B, Sainz V, Scomparin A, Satchi-Fainaro R, Préat V, Florindo HF. Nanoparticle impact on innate immune cell pattern-recognition receptors and inflammasomes activation. Seminars in Immunology. PMID 28941640 DOI: 10.1016/J.Smim.2017.09.003 |
0.295 |
|
2010 |
Weinstain R, Segal E, Satchi-Fainaro R, Shabat D. Real-time monitoring of drug release. Chemical Communications (Cambridge, England). 46: 553-5. PMID 20062859 DOI: 10.1039/B919329D |
0.295 |
|
2018 |
Zafir-Lavie I, Sherbo S, Goltsman H, Badinter F, Yeini E, Ofek P, Miari R, Tal O, Liran A, Shatil T, Krispel S, Shapir N, Neil GA, Benhar I, Panet A, ... Satchi-Fainaro R, et al. Successful intracranial delivery of trastuzumab by gene-therapy for treatment of HER2-positive breast cancer brain metastases. Journal of Controlled Release : Official Journal of the Controlled Release Society. 291: 80-89. PMID 30342077 DOI: 10.1016/J.Jconrel.2018.10.017 |
0.291 |
|
2015 |
Redy-Keisar O, Ferber S, Satchi-Fainaro R, Shabat D. NIR Fluorogenic Dye as a Modular Platform for Prodrug Assembly: Real-Time in vivo Monitoring of Drug Release. Chemmedchem. 10: 999-1007. PMID 25847527 DOI: 10.1002/Cmdc.201500060 |
0.288 |
|
2017 |
Green O, Gnaim S, Blau R, Eldar-Boock A, Satchi-Fainaro R, Shabat D. Near-Infrared Dioxetane Luminophores with Direct Chemiluminescence Emission Mode. Journal of the American Chemical Society. PMID 28853880 DOI: 10.1021/Jacs.7B08446 |
0.287 |
|
2018 |
Acúrcio RC, Scomparin A, Conniot J, Salvador JAR, Satchi-Fainaro R, Florindo HF, Guedes RC. Structure-Function Analysis of Immune Checkpoint Receptors to Guide Emerging Anticancer Immunotherapy. Journal of Medicinal Chemistry. 61: 10957-10975. PMID 30020783 DOI: 10.1021/Acs.Jmedchem.8B00541 |
0.287 |
|
2017 |
Zupančič E, Curato C, Paisana M, Rodrigues C, Porat Z, Viana AS, Afonso CAM, Pinto J, Gaspar R, Moreira JN, Satchi-Fainaro R, Jung S, Florindo HF. Rational design of nanoparticles towards targeting antigen-presenting cells and improved T cell priming. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 28511928 DOI: 10.1016/J.Jconrel.2017.05.014 |
0.287 |
|
2008 |
Ryppa C, Mann-Steinberg H, Fichtner I, Weber H, Satchi-Fainaro R, Biniossek ML, Kratz F. In vitro and in vivo evaluation of doxorubicin conjugates with the divalent peptide E-[c(RGDfK)2] that targets integrin alphavbeta3. Bioconjugate Chemistry. 19: 1414-22. PMID 18578486 DOI: 10.1021/Bc800117R |
0.284 |
|
2011 |
Fante C, Eldar-Boock A, Satchi-Fainaro R, Osborn HM, Greco F. Synthesis and biological evaluation of a polyglutamic acid-dopamine conjugate: a new antiangiogenic agent. Journal of Medicinal Chemistry. 54: 5255-9. PMID 21710976 DOI: 10.1021/Jm200382R |
0.283 |
|
2016 |
Fisusi FA, Siew A, Chooi KW, Okubanjo O, Garrett N, Lalatsa K, Serrano D, Summers I, Moger J, Stapleton P, Satchi-Fainaro R, Schätzlein AG, Uchegbu IF. Lomustine Nanoparticles Enable Both Bone Marrow Sparing and High Brain Drug Levels - A Strategy for Brain Cancer Treatments. Pharmaceutical Research. 33: 1289-303. PMID 26903051 DOI: 10.1007/S11095-016-1872-X |
0.282 |
|
2020 |
Monteran L, Ershaid N, Sabah I, Fahoum I, Zait Y, Shani O, Cohen N, Eldar-Boock A, Satchi-Fainaro R, Erez N. Bone metastasis is associated with acquisition of mesenchymal phenotype and immune suppression in a model of spontaneous breast cancer metastasis. Scientific Reports. 10: 13838. PMID 32796899 DOI: 10.1038/S41598-020-70788-3 |
0.281 |
|
2019 |
Matos AI, Carreira B, Peres C, Moura LIF, Conniot J, Fourniols T, Scomparin A, Martínez-Barriocanal Á, Arango D, Conde JP, Préat V, Satchi-Fainaro R, Florindo HF. Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. 307: 108-138. PMID 31226355 DOI: 10.1016/J.Jconrel.2019.06.017 |
0.275 |
|
2020 |
Shaashua L, Eckerling A, Israeli B, Yanovich G, Rosenne E, Fichman-Horn S, Ben Zvi I, Sorski L, Haldar R, Satchi-Fainaro R, Geiger T, Sloan EK, Ben-Eliyahu S. Spontaneous regression of micro-metastases following primary tumor excision: a critical role for primary tumor secretome. Bmc Biology. 18: 163. PMID 33158447 DOI: 10.1186/s12915-020-00893-2 |
0.274 |
|
2020 |
Shaashua L, Eckerling A, Israeli B, Yanovich G, Rosenne E, Fichman-Horn S, Zvi IB, Sorski L, Haldar R, Satchi-Fainaro R, Geiger T, Sloan EK, Ben-Eliyahu S. Publisher Correction: Spontaneous regression of micro-metastases following primary tumor excision: a critical role for primary tumor secretome. Bmc Biology. 18: 198. PMID 33327952 DOI: 10.1186/s12915-020-00932-y |
0.272 |
|
2014 |
Dvashi Z, Sar Shalom H, Shohat M, Ben-Meir D, Ferber S, Satchi-Fainaro R, Ashery-Padan R, Rosner M, Solomon AS, Lavi S. Protein phosphatase magnesium dependent 1A governs the wound healing-inflammation-angiogenesis cross talk on injury. The American Journal of Pathology. 184: 2936-50. PMID 25196308 DOI: 10.1016/J.Ajpath.2014.07.022 |
0.272 |
|
2020 |
Florindo HF, Kleiner R, Vaskovich-Koubi D, Acúrcio RC, Carreira B, Yeini E, Tiram G, Liubomirski Y, Satchi-Fainaro R. Immune-mediated approaches against COVID-19. Nature Nanotechnology. 15: 630-645. PMID 32661375 DOI: 10.1038/S41565-020-0732-3 |
0.271 |
|
2021 |
Pozzi S, Scomparin A, Israeli-Dangoor S, Rodriguez D, Ofek P, Neufeld L, Krivitsky A, Vaskovich D, Kleiner R, Dey P, Koshrovski S, Reisman N, Satchi-Fainaro R. Meet me halfway: Are in vitro 3D cancer models on the way to replace in vivo models for nanomedicine development? Advanced Drug Delivery Reviews. PMID 33838208 DOI: 10.1016/j.addr.2021.04.001 |
0.266 |
|
2014 |
Redy-Keisar O, Kisin-Finfer E, Ferber S, Satchi-Fainaro R, Shabat D. Synthesis and use of QCy7-derived modular probes for the detection and imaging of biologically relevant analytes. Nature Protocols. 9: 27-36. PMID 24309975 DOI: 10.1038/Nprot.2013.166 |
0.262 |
|
2012 |
Herzog IM, Green KD, Berkov-Zrihen Y, Feldman M, Vidavski RR, Eldar-Boock A, Satchi-Fainaro R, Eldar A, Garneau-Tsodikova S, Fridman M. 6''-Thioether tobramycin analogues: towards selective targeting of bacterial membranes. Angewandte Chemie (International Ed. in English). 51: 5652-6. PMID 22499286 DOI: 10.1002/Anie.201200761 |
0.26 |
|
2019 |
Gnaim S, Scomparin A, Eldar-Boock A, Bauer CR, Satchi-Fainaro R, Shabat D. Light emission enhancement by supramolecular complexation of chemiluminescence probes designed for bioimaging. Chemical Science. 10: 2945-2955. PMID 30996873 DOI: 10.1039/C8Sc05174G |
0.257 |
|
2022 |
Yeini E, Satchi-Fainaro R. The role of P-selectin in cancer-associated thrombosis and beyond. Thrombosis Research. S22-S28. PMID 36210556 DOI: 10.1016/j.thromres.2021.12.027 |
0.255 |
|
2017 |
Shabat D, Hananya N, Green O, Blau R, Satchi-Fainaro R. Highly-Efficient Chemiluminescence Probe for Detection of Singlet Oxygen in Living Cells. Angewandte Chemie (International Ed. in English). PMID 28749072 DOI: 10.1002/Anie.201705803 |
0.248 |
|
2021 |
Yeini E, Ofek P, Pozzi S, Albeck N, Ben-Shushan D, Tiram G, Golan S, Kleiner R, Sheinin R, Israeli Dangoor S, Reich-Zeliger S, Grossman R, Ram Z, Brem H, Hyde TM, ... ... Satchi-Fainaro R, et al. P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression. Nature Communications. 12: 1912. PMID 33771989 DOI: 10.1038/s41467-021-22186-0 |
0.237 |
|
2006 |
Becker C, Wright R, Satchi-Fainaro R, Funakoshi T, Folkman J, Kung A, D'Amato R. Nicht-invasive Überwachung des Effekts antiangiogener Therapie in einem neuartigen transgenen Mausmodell für Endometriose Geburtshilfe Und Frauenheilkunde. 66. DOI: 10.1055/S-2006-952248 |
0.236 |
|
2010 |
Polyak D, Ryppa C, Kratz F, Satchi-Fainaro R. 178 Development of a novel PEG-DOX-E-[c(RGDfK)2] conjugate for avb3 integrin-targeted cancer therapy European Journal of Cancer Supplements. 8: 47. DOI: 10.1016/S1359-6349(10)70985-X |
0.221 |
|
2021 |
Peres C, Matos AI, Moura LIF, Acúrcio RC, Carreira B, Pozzi S, Vaskovich-Koubi D, Kleiner R, Satchi-Fainaro R, Florindo HF. Preclinical models and technologies to advance nanovaccine development. Advanced Drug Delivery Reviews. 172: 148-182. PMID 33711401 DOI: 10.1016/j.addr.2021.03.001 |
0.216 |
|
2017 |
Blau R, Neeman M, Satchi-Fainaro R. Emerging Nanomedical Solutions for Angiogenesis Regulation. Advanced Drug Delivery Reviews. 119: 1-2. PMID 29162250 DOI: 10.1016/J.Addr.2017.11.004 |
0.208 |
|
2010 |
Ofek P, Fischer W, Calderon M, Haag R, Satchi-Fainaro R. 205 In vivo delivery of siRNA to tumours and their vasculature by novel dendritic nanocarriers European Journal of Cancer Supplements. 8: 53-54. DOI: 10.1016/S1359-6349(10)71012-0 |
0.204 |
|
2005 |
Javid PJ, Greene AK, Garza J, Gura K, Alwayn IP, Voss S, Nose V, Satchi-Fainaro R, Zausche B, Mulkern RV, Jaksic T, Bistrian B, Folkman J, Puder M. The route of lipid administration affects parenteral nutrition-induced hepatic steatosis in a mouse model. Journal of Pediatric Surgery. 40: 1446-53. PMID 16150347 DOI: 10.1016/J.Jpedsurg.2005.05.045 |
0.202 |
|
2010 |
Ofek P, Miller K, Eldar-Boock A, Polyak D, Segal E, Satchi-Fainaro R. Rational Design of Multifunctional Polymer Therapeutics for Cancer Theranostics Israel Journal of Chemistry. 50: 185-203. DOI: 10.1002/IJCH.201000020 |
0.201 |
|
2010 |
Ofek P, Miller K, Eldar-Boock A, Polyak D, Segal E, Satchi-Fainaro R. Cover Picture: Rational Design of Multifunctional Polymer Therapeutics for Cancer Theranostics (Isr. J. Chem. 2/2010) Israel Journal of Chemistry. 50: 133-133. DOI: 10.1002/IJCH.201090005 |
0.198 |
|
2016 |
Shaashua L, Sloan E, Satchi-Fainaro R, Ben-Eliyahu S. Abstract # 1800 Promotion of micrometastases by primary tumor secretome, and the deleterious effects of inflammatory surgical-stress responses on dormant metastases Brain, Behavior, and Immunity. 57: e26-e27. DOI: 10.1016/j.bbi.2016.07.089 |
0.196 |
|
2024 |
Monteran L, Ershaid N, Scharff Y, Zoabi Y, Sanalla T, Ding Y, Pavlovsky A, Zait Y, Langer M, Caller T, Eldar-Boock A, Avivi C, Sonnenblick A, Satchi-Fainaro R, Barshack I, et al. Combining TIGIT blockage with MDSC inhibition hinders breast cancer bone metastasis by activating anti-tumor immunity. Cancer Discovery. PMID 38427556 DOI: 10.1158/2159-8290.CD-23-0762 |
0.189 |
|
2019 |
Florindo HF, Madi A, Satchi-Fainaro R. Challenges in the implementation of MIRIBEL criteria on nanobiomed manuscripts. Nature Nanotechnology. 14: 627-628. PMID 31270445 DOI: 10.1038/S41565-019-0498-7 |
0.188 |
|
2023 |
Pires D, Mandal M, Matos AI, Peres C, Catalão MJ, Azevedo-Pereira JM, Satchi-Fainaro R, Florindo HF, Anes E. Development of Chitosan Particles Loaded with siRNA for Cystatin C to Control Intracellular Drug-Resistant . Antibiotics (Basel, Switzerland). 12. PMID 37107091 DOI: 10.3390/antibiotics12040729 |
0.185 |
|
2022 |
Neufeld L, Yeini E, Pozzi S, Satchi-Fainaro R. 3D bioprinted cancer models: from basic biology to drug development. Nature Reviews. Cancer. PMID 36280768 DOI: 10.1038/s41568-022-00514-w |
0.184 |
|
2021 |
Shelef O, Sedgwick AC, Pozzi S, Green O, Satchi-Fainaro R, Shabat D, Sessler JL. Turn on chemiluminescence-based probes for monitoring tyrosinase activity in conjunction with biological thiols. Chemical Communications (Cambridge, England). 57: 11386-11389. PMID 34647549 DOI: 10.1039/d1cc05217a |
0.176 |
|
2018 |
Satchi-Fainaro R. My greatest experiment. Nature Nanotechnology. 13: 176. PMID 29403044 DOI: 10.1038/S41565-018-0064-8 |
0.174 |
|
2006 |
Satchi-Fainaro R, Duncan R, Barnes CM. Polymer therapeutics for cancer: Current status and future challenges Advances in Polymer Science. 193: 1-65. DOI: 10.1007/12_024 |
0.173 |
|
2010 |
David A, Satchi-Fainaro R. Polymer Therapeutics-From Bench to Bedside Israel Journal of Chemistry. 50: 145-146. DOI: 10.1002/IJCH.201000030 |
0.165 |
|
2016 |
Fisusi FA, Siew A, Chooi KW, Okubanjo O, Garrett N, Lalatsa K, Serrano D, Summers I, Moger J, Stapleton P, Satchi-Fainaro R, Schätzlein AG, Uchegbu IF. Lomustine Nanoparticles Enable Both Bone Marrow Sparing and High Brain Drug Levels - A Strategy for Brain Cancer Treatments Pharmaceutical Research. 33: 1289-1303. DOI: 10.1007/s11095-016-1872-x |
0.156 |
|
2021 |
Đorđević S, Gonzalez MM, Conejos-Sánchez I, Carreira B, Pozzi S, Acúrcio RC, Satchi-Fainaro R, Florindo HF, Vicent MJ. Current hurdles to the translation of nanomedicines from bench to the clinic. Drug Delivery and Translational Research. PMID 34302274 DOI: 10.1007/s13346-021-01024-2 |
0.144 |
|
2021 |
Yanovich-Arad G, Ofek P, Yeini E, Mardamshina M, Danilevsky A, Shomron N, Grossman R, Satchi-Fainaro R, Geiger T. Proteogenomics of glioblastoma associates molecular patterns with survival. Cell Reports. 34: 108787. PMID 33657365 DOI: 10.1016/j.celrep.2021.108787 |
0.126 |
|
2012 |
Herzog IM, Green KD, Berkov-Zrihen Y, Feldman M, Vidavski RR, Eldar-Boock A, Satchi-Fainaro R, Eldar A, Garneau-Tsodikova S, Fridman M. Innentitelbild: 6′′-Thioether Tobramycin Analogues: Towards Selective Targeting of Bacterial Membranes (Angew. Chem. 23/2012) Angewandte Chemie. 124: 5602-5602. DOI: 10.1002/Ange.201203240 |
0.125 |
|
2019 |
Shabat D, Hananya N, Press O, Das A, Scomparin A, Satchi-Fainaro R, Sagi I. Persistent Chemiluminescent Glow of Phenoxy-Dioxetane Luminophore Enables Unique CRET-Based Detection of Proteases. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 31495978 DOI: 10.1002/Chem.201903489 |
0.123 |
|
2018 |
Pozzi S, Scomparin A, Ofek P, Yeini E, Ben-Shushan D, Eldar-Boock A, Tiram G, Satchi-Fainaro R. PO-200 Prevention of melanoma brain colonisation by inhibiting cytokines secretion from activated astrocytes Esmo Open. 3: A98. DOI: 10.1136/esmoopen-2018-EACR25.235 |
0.115 |
|
2018 |
Yeini E, Ofek P, Tiram G, Satchi-Fainaro R. PO-367 Brain microenvironment-secreted cytokines facilitate glioblastoma proliferation and invasion Esmo Open. 3: A372. DOI: 10.1136/esmoopen-2018-EACR25.878 |
0.113 |
|
2022 |
Acúrcio RC, Pozzi S, Carreira B, Pojo M, Gómez-Cebrián N, Casimiro S, Fernandes A, Barateiro A, Farricha V, Brito J, Leandro AP, Salvador JAR, Graça L, Puchades-Carrasco L, Costa L, ... Satchi-Fainaro R, et al. Therapeutic targeting of PD-1/PD-L1 blockade by novel small-molecule inhibitors recruits cytotoxic T cells into solid tumor microenvironment. Journal For Immunotherapy of Cancer. 10. PMID 35863821 DOI: 10.1136/jitc-2022-004695 |
0.11 |
|
2022 |
Satchi-Fainaro R, Florindo HF, Vicent MJ. Clinically-relevant and predictive cancer models for nanomedicine evaluation. Advanced Drug Delivery Reviews. 183: 114140. PMID 35134434 DOI: 10.1016/j.addr.2022.114140 |
0.086 |
|
2010 |
Fischer W, Claderon M, Ofek P, Satchi-Fainaro R, Haag R. siRNA transfection by dendritic core-shell nanocarriers. Journal of Controlled Release : Official Journal of the Controlled Release Society. 148: e89. PMID 21529651 DOI: 10.1016/j.jconrel.2010.07.064 |
0.08 |
|
2022 |
Sekhar AR, Chitose Y, Janoš J, Dangoor SI, Ramundo A, Satchi-Fainaro R, Slavíček P, Klán P, Weinstain R. Porphyrin as a versatile visible-light-activatable organic/metal hybrid photoremovable protecting group. Nature Communications. 13: 3614. PMID 35750661 DOI: 10.1038/s41467-022-31288-2 |
0.066 |
|
Hide low-probability matches. |